Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | cerivastatin | |
Synonyms |
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))- Certa Baycol Kazak rivastatin cerivastatin sodium Bay w 6228 Lipobay 7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate sodium salt |
|
ID |
http://purl.bioontology.org/ontology/MESH/C086276 |
|
altLabel |
6-Heptenoic acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, monosodium salt, (S-(R*,S*-(E)))- Certa Baycol Kazak rivastatin cerivastatin sodium Bay w 6228 Lipobay 7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate sodium salt
|
|
cui |
C1530129 C0252746 C0724549 C0718827 C1174744 C0528023
|
|
HM |
D011725
|
|
Inverse of RB |
AM91H2KS67
|
|
isa | ||
LT |
TRD
|
|
Mapped to | ||
MDA |
19940413
|
|
MeSH Frequency |
530
|
|
MMR |
20141022
|
|
notation |
C086276
|
|
PA |
D019161
|
|
prefLabel |
cerivastatin
|
|
SC |
1
|
|
Scope Statement |
cerivastatin is the ((E)-(+))-isomer; structure given in first source
|
|
SRC |
J Pharm Biomed Anal 1993 Nov-Dec;11(11-12):1269-75
|
|
TERMUI |
T461013 T624540 T258734 T461012 T258735 T258733 T624538 T420190 T534913 T258732
|
|
TH |
US NLM (2004) FDA SRS (2013) NLM (2001) NLM (1994) INN (19XX) NLM (2003) AU IE
|
|
tui |
T109 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping